Author Archive: AZBio
Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died
Merck Plans to Seek Emergency Use Authorization in the U.S. as Soon as Possible and to Submit Applications to Regulatory Agencies Worldwide
If Authorized, Molnupiravir Could be the First Oral Antiviral Medicine for COVID-19Continue reading
Arizona Bioindustry Association Honored For Leadership at Arizona Business Innovation Awards
On Sep 30, 2021, the Arizona Business Innovation Awards, presented by Az Business magazine honored the 30 most innovative companies in Arizona. In addition to honoring the 30 most innovative companies in Arizona for 2021, the judges also selected five spotlight award winners for exceptional achievement.Continue reading
Applications for the 2022 KEYS Internship Program Open Oct 1
The University of Arizona BIO5 Institute KEYS Research Internship recruitment for KEYS 2022 has officially begun!
Continue reading
Castle Biosciences President and CEO Derek Maetzold Will Deliver Keynote Presentation During Arizona Bioscience Week
Maetzold’s presentation will take place during the AZAdvances Life Science Innovation Showcase on October 6Continue reading
UArizona Cancer Center Researchers Identify Mechanism for Slowing Cancer Growth
Humabiologics becomes ISO 13485 Certified and GMP Compliant Manufacturer
The ISO 13485:2016 registration positions Humabiologics among the first global providers of GMP (Good Manufacturing Practices) grade human-derived biomaterials to support and expedite the future development of human regenerative therapies and tissue models for drug discovery through clinically relevant high-quality products. Continue reading
Are Innovations in Chemistry Your Thing? Apply to Present in the Scorpion Pit
RMRM 2021 Scorpion Pit Competition
Tucson Marriott University Park, Tucson, Arizona
Thursday, October 21, 2021 5:00 – 7:00 PMContinue reading
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
Trial provides proof of concept for this new metabolically targeted, rapidly acting technology platform for brain tumors and other lethal cancersContinue reading
Here’s how the Arizona bioscience sector is pioneering innovations
The pace of medical innovation is accelerating around the world and right here in the Arizona bioscience sector. Biomedical innovators are pioneering in the fields of diagnostics, treatments, medical devices, and health technologies.Continue reading